Medtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and confirmed that the randomised controlled trial of INFUSE Bone Graft in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback